- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Bajaj Healthcare Limited — Updates, 31-12-2025: General Updates
31-12-2025 | 07:18 pm
31-12-2025 | 07:18 pm
Bajaj Healthcare received CDSCO approval to conduct Clinical Trial and Bioequivalence Study for Suvorexant Tablets. This critical development advances the drug's path towards commercialization, following prior expert committee input.
No comments yet. Be the first to comment!